Biotech · Private company
Aerogen Pharma Limited
Track this companyFree. Adds Aerogen Pharma Limited to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- APC-0101 (SF-RI 1 surfactant for inhalation combined with a dedicated delivery system)Phase 3 · Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ControlPhase 3 · Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- AeroFactPhase 2 · Respiratory Distress Syndrome in Premature InfantClinicalTrials.gov · fetched Nov 12, 2026
- nCPAPPhase 2 · Respiratory Distress Syndrome in Premature InfantClinicalTrials.gov · fetched Nov 12, 2026
- VentaProstPhase 2 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- VentaProst (inhaled epoprostenol delivered via a dedicated delivery system)Phase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress SyndromePHASE3 · RECRUITING · started Sep 24, 2025ClinicalTrials.gov NCT06776783 · fetched Nov 12, 2026
- VentaProst in Subjects With COVID-19 Requiring Mechanical VentilationPHASE2 · COMPLETED · started Sep 15, 2020ClinicalTrials.gov NCT04452669 · fetched Nov 12, 2026
- A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFactPHASE2 · COMPLETED · started Mar 4, 2020ClinicalTrials.gov NCT03969992 · fetched Nov 12, 2026
- VentaProst Versus Conventionally-Administered Aerosolized Epoprostenol in Patients Undergoing Cardiac Surgery With CPBPHASE2 · COMPLETED · started Aug 23, 2017ClinicalTrials.gov NCT03122730 · fetched Nov 12, 2026